Post

New research · Rheumatology
The Journal of rheumatology · 21h
Cohort studyThe Journal of rheumatology · 2026

Understanding the impact of meeting performance measures on the outcomes of joint replacement in rheumatoid arthritis: a population-based study in British Columbia, Canada.

Claire E H Barber, Hui Xie, Yufei Zheng … Diane Lacaille
Read paper
RheumatologyCohort study

Annual disease-modifying antirheumatic drug therapy was associated with a slightly higher 10-year risk of total joint replacement.

Understanding the impact of meeting performance measures on the outcomes of joint replacement in rheumatoid arthritis: a population-based study in British Columbia, Canada.

Claire E H Barber … Diane Lacaille
The Journal of rheumatology · 2026
Background

Canadian performance measures (performance measures) evaluate the quality of rheumatoid arthritis (rheumatoid arthritis) care; however limited evidence exists linking these process measures to long-term patient outcomes.

Purpose

Canadian performance measures (performance measures) evaluate the quality of rheumatoid arthritis (rheumatoid arthritis) care; however limited evidence exists linking these process measures to long-term patient outcomes.

Methods

This was a retrospective propensity-score matched population-based cohort study in people with rheumatoid arthritis diagnosed between 2000 and 2008 who were followed until 2019.

n = 19,765 individuals
Results

annual rheumatoid arthritis medication was linked to a slightly higher 10-year risk of joint replacement

HR 1.19 (95% CI 1.03 to 1.37)
null 1
1.03
1.37
CI excludes the null - significant
More results

Among 19,765 individuals with rheumatoid arthritis, 44.78% had access to a rheumatologist within one year of diagnosis; 24.91% were retained in care, while only 24.30% were dispensed a DMARD within 30 days, and 32.66% received a DMARD annually for the first 2 years.

“
Conclusion · 1 of 2

There were deficits in rheumatoid arthritis care identified at a population-level; however, no clear protective effect of adherence to performance measures was found.

Conclusion · 2 of 2

Future measure development efforts should focus on measures with a greater impact on patient outcomes.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Case Report
creatinine at 6.28 mg/dL
high level of a waste product, indicating severe kidney damage
Guideline
≥80% acceptance
most experts accepted the new treatment recommendations
Study
80% (4/5)
Four out of five patients with refractory systemic lupus erythematosus achieved remission.
Review
73%
patient-reported symptoms were used more often to define ongoing symptoms
Cohort Study
AUC of 0.804
how well the three-gene model identifies Dampness ZHENG
Cohort Study
OR 0.70
Odds of valve progression or new valve disease were similar with prophylaxis.
Study
AUC = 0.847
Good accuracy separating lupus patients from healthy people (higher AUC = better)
AI / Informatics
accuracy 0.731
the computer model correctly identified juvenile arthritis activity levels nearly three-quarters of the time